不同剂量促红细胞生成素对于早产儿神经发育的作用被引量：4

Different doses of erythropoietin protect neural development in premature infant

导出

摘要目的探讨不同剂量促红细胞生成素(rhEPO),对早产儿神经系统发育的影响。方法入住本院NICU病房的早产儿,按入院先后次序分为rhEPO组(治疗组)和对照组,其中治疗组120例,对照组30例,其中rhEPO治疗组又随机分为3组,低剂量组(750 U·周·kg^(-1)),中等剂量组(1 500 U·周·kg^(-1)),高剂量组2 000 U·周·kg^(-1))。比较2组早产儿在纠正胎龄40周时的新生儿神经行为测定(NBNA)评分和6,12月时的Gesell发育量表的评估得分。结果 rhEPO组NBNA评分显著高于对照组,中等剂量和高剂量组分别优于低剂量组(P<0.05),中等剂量和高剂量组无明显差异;生后6个月时rhEPO组优于对照组大运动和适应能力,12个月时大运动、语言能力及精细动作得分实验组亦高于对照组(P<0.05)。结论早期使用大剂量EPO可显著改善早产儿预后,促进其神经系统发育。 Objective This study of rhEPO treatment in premature,observe whether rhEPO has influence to the development of the nervous system in premature infants,and the effect of different doses have differences.Methods In our NICU ward of premature infants.According to admission order divided into rhEPO treatment group and control group,the treatment group 120 cases,control group 30 cases,Including rhEPO treatment group was randomly divided into three groups,low doses of 750 u·W^（- 1）·kg^（- 1）,medium dose of1 500 u·W^（- 1） kg^（- 1）,high dose of 2 000 u·W^（- 1） kg^（- 1）.Compare two groups of premature infants in the correct determination of neonatal neurobehavioral gestational age at 40 weeks（NBNA）scores and 6 and 12 months of Gesell developmental scale assessment score.Results RhEPO group＇s NBNA score significantly higher than that of control group,Moderate dose and high dose group＇s score higher than the low dose group,middle dose and high dose group,no difference;treatment group after 6,12 months for two groups of children with evaluation of Gesell developmental scale,6 months big movement and the ability to adapt the experimental group is better than that of control group,12 months big movement,language and fine motor score of experimental group is higher than that of control group,compared to similar between the two groups have statistical significance.Conclusion The early use of large dose of rhEPO can significantly improve the prognosis of premature infants,promote the development of the nervous system.

作者祝炼刘春梅谢莉莉李晓鸥方成志

机构地区湖北省孝感市妇幼保健院新生儿科武汉大学人民医院新生儿科

出处《卒中与神经疾病》 2016年第1期9-12,共4页 Stroke and Nervous Diseases

关键词促红细胞生成素早产儿神经发育 Recombinant human erythropoietin Premature infants Nervous system

分类号 R743 [医药卫生—神经病学与精神病学]

引文网络
相关文献

参考文献17

1Zhou TF,Yu JG.Recombinant human erythropoietin attenuates neuronal apoptosis and cognitive defects via JAK2/STAT3 signaling in experimental endotoxemia[J].J Surg Res,2013,183(1):304-312.
2Elmahdy H,El-Mashad AR,El-Bahrawy H,et al.Human recombinant erythropoietin in asphyxia neonatorum:pilot trial[J].Pediatrics,2010,125(5):e1135-e1142.
3Bendix I,Schulze C,Haefen Cv,et al.Erythropoietin modulates autophagy signaling in the developing rat brain in an in vivo model of oxygen-toxicity[J].Int J Mol Sci,2012,13(10):12939-12951.
4Turner JD,Mammis A,Prestigiacomo CJ.Erythropoietin for the treatment of subarachnoid hemorrhage:a review[J].World Neurosurg,2010,73(5):500-507.
5Fan X,Van Bel F,Van Der Kooij MA,et al.Hypothermia and erythropoietin for neuroprotection after neonatal brain damage[J].Pediatr Res,2013,73(1):18-23.
6Springborg JB,M?ller C,Gideon P,et al.Erythropoietin in patients with aneurysmal subarachnoid haemorrhage:a double blind randomised clinical trial[J].Acta Neurochir(Wien),2007,149(11):1089-1101;discussion 1101.
7Tseng MY,Hutchinson PJ,Richards HK,et al.Acute systemic erythropoietin therapy to reduce delayed ischemic deficits following aneurysmal subarachnoid hemorrhage:a Phase II randomized,double-blind,placebo-controlled trial.Clinical article[J].J Neurosurg,2009,111(1):171-180.
8Wu YW,Bauer LA,Ballard RA,et al.Erythropoietin for neuroprotection in neonatal encephalopathy:safety and pharmacokinetics[J].Pediatrics,2012,130(4):683-691.
9Kumral A,Tüzün F,Oner MG,et al.Erythropoietin in neonatal brain protection:the past,the present and the future[J].Brain Dev,2011,33(8):632-643.
10Müller B,Evangelopoulos DS,Bias K,et al.Can S-100B serum protein help to save cranial CT resources in a peripheral trauma centre?A study and consensus paper[J].Emerg Med J,2011,28(11):938-940.

二级参考文献20

1马海燕,牛余宗.早产儿脑室周围白质软化发病机制的研究进展[J].实用儿科临床杂志,2005,20(2):175-177. 被引量：4
2姚裕家.早产儿脑损伤的病因及病理生理机制研究进展[J].临床儿科杂志,2006,24(3):166-167. 被引量：38
3Brines ML, Ghezzi P, Keenan S, et al. Erythropoietin crosses the blood- brain barrier to protect against experimental brain injury[J ].Proc Natl Acad Sci USA, 2000,97( 19):10526- 10531.
4Neumann D, Yuk MH, Lodish HF, et al. Blocking intracellular intracellular degradation of the erythropoietin and asialoglycoprotein receptors by calpain inhibitors does not result in the memberane and secreted forms [J ]. Biochem J, 1996,313: 391 - 399.
5Grasso G, Buemi M, Alafaci C, et al. Beneficial effects of systemic administration of recombinant human erythropoetin in rabbits subjected to subarachnoid hemorrhage[J ]. Proc Natl Acad Sci USA,2002,99: 5627 - 5631.
6Martinez- Estrada OM, Rodriguez- Millan E, de Vicente EG, et al. Erythropoietin protects the in vitro blood- brain barrier against VEGF- induced permeability [J ]. Eur J Neuroc, 2003,18: 2538 -2544.
7Juul SE, McPherson RJ, Farrell FX, et al. Erythropoietin concentrations in cerebrospinal fluid of nonhuman primates and fetal sheep following high - dose recombinant erythropoietin [J ]. Biol Neonate,2004,85:138 - 144.
8Springborg JB, Ma X, Rochat P, et al. A single subcutaneous bolus of erythropoietin normalizes cerebral blood flow autoregulation after subarachnoid haemorrhage in rats [J ]. Br J Pharmacol,2002,135:823 - 829.
9Kumral A, Ozer E, Yilmaz O, et al. Neuroprotective effect of erythropoietin on hypoxic - ischemic brain injury in neonatalrats [J ].Biol Neonate, 2003,83: 224 - 228.
10Eid T, Brines M. Recombinant human erythropoetin for neuroprotection: What is the evidence[J ]. Clin Breast Cancer Suppl, 2002,3(3):109- 115.